U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG,; Trademark Departmen |
---|---|
Address | Novartis Pharma AG,; Trademark Departmen Postfach CH-4002 Basel SWITZERLAND, |
Date | Description | Action Tags | Code |
---|---|---|---|
Jan-19-2023 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | LIMNI | |
Nov-06-2022 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | DENCO | |
Nov-06-2022 | DEATH OF INTERNATIONAL REGISTRATION | DETHP | |
Jun-03-2022 | LIMITATION FROM THE IB EXAMINED AND ENTERED | LIMEI | |
May-29-2022 | CORRECTION UNDER SECTION 7 ¿ PROCESSED | COC.O | |
Jul-06-2020 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | INNAR | |
Jun-18-2020 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | INPRP | |
Oct-19-2019 | LIMITATION FROM THE IB EXAMINED AND ENTERED | LIMEI | |
Oct-18-2019 | CORRECTION UNDER SECTION 7 ¿ PROCESSED | COC.O | |
Oct-04-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Oct-04-2019 | LIMITATION OF GOODS RECEIVED FROM IB | LIMGM | |
Sep-27-2019 | LIMITATION OF GOODS RECEIVED FROM IB | LIMGM | |
Sep-17-2019 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Sep-17-2019 | FINAL DISPOSITION PROCESSED | FIMPP | |
Aug-29-2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Jul-30-2019 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Jun-23-2019 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | ETOPT | |
Feb-27-2019 | EXTENSION OF TIME TO OPPOSE RECEIVED | ETOFT | |
Feb-12-2019 | PUBLISHED FOR OPPOSITION | PUBOA | |
Feb-08-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Jan-23-2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Jan-23-2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Jan-23-2019 | NOTICE OF PUBLICATION | NPUBO | |
Jan-08-2019 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Jan-05-2019 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Jan-03-2019 | ASSIGNED TO EXAMINER | DOCKD | |
Jan-02-2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Dec-28-2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Dec-27-2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM |